It’s easier than ever for doctors to prescribe a key medicine for opioid addiction since the U.S. government lifted an obstacle last year. But despite the looser restrictions and the ongoing overdose crisis, a new study finds little change in the number of people taking the medication.
Researchers analyzed prescriptions filled by U.S. pharmacies for the treatment drug buprenorphine. The number of prescribers rose last year after doctors no longer needed to get a special waiver to prescribe the drug, while the number of patients filling prescriptions barely budged.
It may take more than one year to see a bigger increase in patients, said study co-author Dr. Kao-Ping Chua of the University of Michigan Medical School.
“There are so many other barriers to prescribing that we have to address,” said Chua.
The findings were published Wednesday in the New England Journal of Medicine.
U.S. bears a lot of responsibility for deglobalization trend: former Secretary of Commerce
Mideast in Pictures: Long road to recovery awaits quake
Kristalina Georgieva to serve second term as IMF managing director
Orpheus Pledger: Home and Away star is arrested after sparking a three
Xinhua Headlines: Key Takeaways from Xi's Diplomacy in 2023
UN chief calls for restraint after Iran's retaliatory attacks on Israel
CPPCC National Committee Holds Gathering to Ring in New Year, Xi Jinping Delivers Important Speech
Uruguay goalkeeper Fernando Muslera retires from international soccer
Imposing travel restrictions for China arrivals scientifically unjustified: ACI EUROPE
Taylor Swift flew her private jets 178,000 miles last year for her Eras Tour
IAEA chief calls for "maximum restraint" over Zaporizhzhia attacks